8.2 Cell sourcing and expansion
4 min read•july 30, 2024
Cell sourcing and expansion are crucial aspects of . They involve selecting appropriate cell types, isolating them from tissues, and growing them in sufficient quantities for use in regenerative therapies.
This process faces challenges like limited cell availability, maintaining cell quality during expansion, and overcoming immune rejection. Various cell sources, including stem cells, offer unique advantages and limitations that must be carefully considered in tissue engineering applications.
Cell Sources for Tissue Engineering
Types of Cell Sources
Top images from around the web for Types of Cell Sources
Frontiers | Stem Cell Mechanobiology and the Role of Biomaterials in Governing ... View original
Is this image relevant?
Cellular Differentiation | Anatomy and Physiology I View original
Is this image relevant?
Stem Cells & Regenerative Medicine MFA | CHDI Foundation View original
Is this image relevant?
Frontiers | Stem Cell Mechanobiology and the Role of Biomaterials in Governing ... View original
Is this image relevant?
Cellular Differentiation | Anatomy and Physiology I View original
Is this image relevant?
1 of 3
Top images from around the web for Types of Cell Sources
Frontiers | Stem Cell Mechanobiology and the Role of Biomaterials in Governing ... View original
Is this image relevant?
Cellular Differentiation | Anatomy and Physiology I View original
Is this image relevant?
Stem Cells & Regenerative Medicine MFA | CHDI Foundation View original
Is this image relevant?
Frontiers | Stem Cell Mechanobiology and the Role of Biomaterials in Governing ... View original
Is this image relevant?
Cellular Differentiation | Anatomy and Physiology I View original
Is this image relevant?
1 of 3
- derived from the patient's own body minimize the risk of immune rejection but may be limited in availability or quality depending on the patient's age and health status
- obtained from donors of the same species provide a more readily available source but require immunosuppression to prevent rejection
- derived from different species (porcine or bovine) offer a potentially unlimited supply but present significant immunological and safety challenges
Stem Cells as Cell Sources
- generated from a patient's own somatic cells provide an autologous source with the potential to differentiate into various cell types
- derived from the inner cell mass of blastocysts possess pluripotency but their use is associated with ethical concerns and potential tumorigenicity
- (mesenchymal stem cells) isolated from various tissues have the ability to differentiate into multiple cell lineages making them a promising cell source for tissue engineering applications
Cell Isolation and Expansion
Cell Isolation and Purification Techniques
- Effective methods (enzymatic digestion or mechanical dissociation) are crucial for obtaining a sufficient number of viable cells from the desired tissue source
- Purification techniques including density gradient centrifugation, fluorescence-activated cell sorting (FACS), and magnetic-activated cell sorting (MACS) enrich the desired cell population and remove unwanted cell types or contaminants
- Xeno-free and conditions are desirable for clinical applications to minimize the risk of contamination and immunological reactions
Cell Expansion Strategies
- Cell expansion is necessary to obtain a sufficient number of cells for tissue engineering applications as the initial cell yield from isolation is often limited
- Bioreactor systems ( or ) provide optimal conditions for cell expansion including controlled temperature, pH, and nutrient supply
- using or facilitate cell growth and maintain cell phenotype during the expansion process
Stem Cells in Tissue Engineering
Stem Cell Characteristics and Differentiation
- Stem cells are characterized by their ability to self-renew and differentiate into various cell types making them a promising cell source for tissue regeneration
- guide stem cells towards specific cell lineages (osteoblasts, chondrocytes, cardiomyocytes) for targeted tissue engineering applications
- Stem cell-derived have emerged as a cell-free approach to deliver regenerative factors and modulate the local microenvironment to promote tissue repair
Stem Cell Types and Their Applications
- Embryonic stem cells (ESCs) are pluripotent, capable of giving rise to all three germ layers (endoderm, mesoderm, ectoderm) but their use is associated with ethical concerns and potential tumorigenicity
- Adult stem cells (mesenchymal stem cells, ) are multipotent and can differentiate into a limited number of cell lineages
- Induced pluripotent stem cells (iPSCs) generated by reprogramming somatic cells to a pluripotent state offer the potential for patient-specific cell therapies without the ethical issues associated with ESCs
Challenges of Cell Sourcing and Expansion
Limitations in Cell Availability and Quality
- Limited cell availability from certain tissue sources (primary human cells) can hinder the scalability and widespread application of tissue engineering strategies
- Donor variability in terms of age, health status, and genetic background impacts the quality and functionality of isolated cells leading to inconsistent outcomes
- Senescence, characterized by a decrease in cell proliferation and altered cell function, limits the expansion potential of primary cells and impacts their therapeutic efficacy
Phenotypic Instability and Variability
- Phenotypic instability, particularly in stem cells, can occur during extended in vitro culture resulting in a loss of differentiation potential or uncontrolled differentiation
- Batch-to-batch variability in cell isolation and expansion processes leads to inconsistencies in cell quality and hinders the reproducibility of tissue engineering approaches
Regulatory and Immunological Challenges
- Regulatory challenges, including the need for good manufacturing practices (GMP) compliance and extensive safety testing, increase the cost and time required for cell-based therapy development
- Immunogenicity of allogeneic and xenogeneic cell sources remains a significant challenge requiring the development of effective immunomodulation strategies or the use of autologous or hypoimmunogenic cell sources
Key Terms to Review (26)
Adult stem cells: Adult stem cells are a type of stem cell found in various tissues of the body that have the ability to differentiate into specialized cell types. They play a crucial role in tissue repair and regeneration, maintaining homeostasis and contributing to the body's response to injury, making them significant for various medical applications and therapies.
Allogeneic cells: Allogeneic cells are cells that are derived from a donor of the same species but genetically distinct from the recipient. This type of cell sourcing is critical in regenerative medicine as it allows for the transplantation of tissues or organs without requiring a perfect genetic match, making it possible to utilize a wider pool of donors. Allogeneic cells can be sourced from cadavers, living donors, or cell banks, and they play an essential role in therapies such as stem cell transplants and tissue engineering.
Autologous Cells: Autologous cells are cells that are derived from the same individual to whom they will be applied or transplanted. This concept is crucial in regenerative medicine, as it minimizes the risk of immune rejection and complications associated with using cells from different donors, thus allowing for personalized treatment strategies that promote better integration and healing.
Cell isolation: Cell isolation is the process of separating specific cells from a mixture, often to obtain a pure population for research or therapeutic applications. This technique is essential in regenerative medicine as it enables scientists to study individual cell types, understand their functions, and expand them for further applications, such as tissue engineering or cell therapy.
Cell Purification: Cell purification is the process of isolating specific cell types from a mixed population to obtain a homogeneous cell sample for research or therapeutic applications. This technique is essential in regenerative medicine, as it enables the selection of desired cells that can promote healing and tissue regeneration, while eliminating unwanted or contaminated cells.
Cell Replacement Therapy: Cell replacement therapy is a regenerative medicine technique that involves replacing damaged or lost cells with healthy ones to restore function in tissues or organs. This approach is often used to treat diseases such as diabetes, neurodegenerative disorders, and heart disease, aiming to repair or regenerate tissue that has been affected by injury or disease.
Cell therapy regulations: Cell therapy regulations are legal and ethical frameworks that govern the use of cellular therapies in medical practice, ensuring patient safety and efficacy. These regulations aim to standardize practices surrounding the sourcing, processing, and application of cells used for therapeutic purposes, thereby promoting safe clinical outcomes while fostering innovation in regenerative medicine.
Directed Differentiation Protocols: Directed differentiation protocols are systematic methods used to guide stem cells or progenitor cells into specific cell types through controlled environmental conditions and signaling pathways. This process is crucial for regenerative medicine as it allows for the production of desired cell types for research, disease modeling, and potential therapeutic applications.
Donor eligibility: Donor eligibility refers to the criteria that determine whether an individual can donate cells or tissues for regenerative medicine purposes. These criteria are essential to ensure the safety, efficacy, and quality of the donated material, ultimately impacting the success of cell sourcing and expansion processes. Factors such as medical history, age, and lifestyle choices play a critical role in assessing an individual's eligibility to donate.
Embryonic stem cells (ESCs): Embryonic stem cells (ESCs) are pluripotent cells derived from the inner cell mass of early-stage embryos, specifically the blastocyst stage. These cells have the unique ability to differentiate into any cell type in the body, making them a critical resource in regenerative medicine and tissue engineering. Their capacity for self-renewal and versatility makes them a valuable tool for research and potential therapeutic applications.
Extracellular vesicles (EVs): Extracellular vesicles (EVs) are small, membrane-bound structures released by cells into the extracellular environment, playing essential roles in intercellular communication and the transfer of biomolecules. These vesicles can carry proteins, lipids, and nucleic acids, influencing various physiological and pathological processes, including tissue repair and immune responses. Their ability to facilitate communication between different cell types makes them crucial in regenerative medicine and cell sourcing.
Good Manufacturing Practice (GMP): Good Manufacturing Practice (GMP) refers to a system of guidelines and regulations that ensure products are consistently produced and controlled according to quality standards. These practices are crucial in the production of biologics and cell therapies, emphasizing quality control and risk management throughout the manufacturing process. Adhering to GMP helps to ensure safety, efficacy, and quality of medical products, which is vital for patient trust and regulatory compliance.
Growth Factors: Growth factors are naturally occurring proteins that play a crucial role in regulating various cellular processes, including cell proliferation, differentiation, and survival. These signaling molecules are vital for tissue repair and regeneration, influencing how cells respond to their environment and interact with one another.
Hematopoietic Stem Cells: Hematopoietic stem cells (HSCs) are multipotent stem cells found primarily in the bone marrow, responsible for the generation of all blood cell types, including red blood cells, white blood cells, and platelets. They play a crucial role in the field of regenerative medicine, as they can be isolated, expanded, and utilized for therapeutic applications, particularly in treating blood disorders and cancers.
Induced pluripotent stem cells (iPSCs): Induced pluripotent stem cells (iPSCs) are a type of stem cell that can be generated from adult cells through the introduction of specific genes and factors, reprogramming them back into a pluripotent state. This unique ability allows iPSCs to differentiate into virtually any cell type in the body, making them a powerful tool for regenerative medicine, cell sourcing, and tissue engineering applications.
Informed Consent: Informed consent is the process by which individuals voluntarily agree to participate in a medical treatment or research study after being fully informed about its risks, benefits, and alternatives. This process is crucial in ensuring that participants understand their rights, the nature of the intervention, and the potential outcomes involved, particularly in sensitive areas like regenerative medicine and stem cell research.
Microcarriers: Microcarriers are small, spherical particles that provide a surface for anchorage-dependent cells to grow in suspension culture. They play a crucial role in cell sourcing and expansion by facilitating the large-scale cultivation of cells needed for various regenerative medicine applications. By offering a larger surface area for cell attachment, microcarriers enhance cell density and productivity, making them essential in bioprocessing.
Niche environment: A niche environment refers to the specific and unique conditions in which a particular cell type thrives, including its surrounding physical, chemical, and biological factors. This term is crucial as it impacts cell behavior, function, and growth, and plays a vital role in the sourcing and expansion of cells for regenerative medicine applications.
Perfusion Bioreactors: Perfusion bioreactors are advanced cell culture systems that maintain a continuous flow of nutrients and oxygen to cells while removing waste products. This dynamic environment promotes optimal cell growth and metabolism, which is crucial for the development of engineered tissues and regenerative therapies. They are particularly important in scaling up cell sourcing and expansion, as well as in providing the mechanical and biochemical signals needed for tissue engineering applications.
Scaffold-based expansion techniques: Scaffold-based expansion techniques are methods used to grow and expand cells on a three-dimensional structure, known as a scaffold, that mimics the natural extracellular matrix. These techniques are essential in regenerative medicine as they provide a supportive environment for cell attachment, proliferation, and differentiation, ultimately enhancing tissue engineering applications.
Self-renewal: Self-renewal is the process by which stem cells maintain their population through division, producing identical daughter cells that retain the same stem cell properties. This ability is crucial for tissue homeostasis and regeneration, allowing stem cells to provide a continuous source of new cells while also replacing lost or damaged cells. The mechanisms of self-renewal are influenced by various factors, including signaling pathways, transcription factors, and the surrounding microenvironment.
Serum-free culture: Serum-free culture refers to the method of growing cells without the addition of serum, such as fetal bovine serum (FBS), which is typically used as a source of nutrients and growth factors. This approach helps to create a more controlled environment for cell growth, reducing variability caused by serum components and facilitating better study of cell behavior, differentiation, and response to treatments.
Spinner flasks: Spinner flasks are bioreactor devices designed to culture cells in a liquid medium, providing a controlled environment for cell growth and expansion. These flasks utilize a spinning mechanism to promote homogenous mixing and enhance oxygen transfer, making them particularly useful for large-scale cell expansion in regenerative medicine applications.
Three-dimensional (3D) matrices: Three-dimensional (3D) matrices are structures that provide a scaffold for cells to grow and organize in three dimensions, mimicking the natural environment found in tissues. These matrices allow for better cell interactions and can enhance cellular functions, making them crucial for tissue engineering and regenerative medicine. By providing a supportive framework, 3D matrices facilitate the expansion and differentiation of various cell types, leading to improved outcomes in cellular therapies.
Tissue engineering: Tissue engineering is a multidisciplinary field that focuses on the development of biological substitutes to restore, maintain, or improve tissue function. This field combines principles from biology, materials science, and engineering to create scaffolds that can support the growth and regeneration of tissues and organs, playing a critical role in regenerative medicine.
Xenogeneic Cells: Xenogeneic cells are cells that are derived from a different species than the one being treated or observed. These cells can be used in regenerative medicine for various applications, including tissue engineering and transplantation, as they offer unique properties that can be beneficial in certain scenarios. Understanding the characteristics and potential uses of xenogeneic cells is crucial for advancements in cell sourcing and expansion techniques.